Experimental study demonstrates that methotrexate suppresses testicular steroidogenesis and lowers testosterone in adult rats, indicating impaired male endocrine function unmitigated by leucovorin.
The effects of single dose, 4 consecutive days, 4 and 8 weekly doses of methotrexate (MTX) treatment (3 mg/kg body weight, intramuscularly) with and without leucovorin (LCN) supplementation (0.3 mg/kg body weight, intramuscularly) on serum testosterone titres, total, free and esterified cholesterol concentrations and steroidogenic enzymes, viz. 3beta- and 17beta-hydroxy steroid dehydrogenase activities were studied in adult albino rats. MTX treatment caused a marked reduction in serum testosterone titres in all the treatment groups in a duration-dependent manner. LCN supplementation did not restore serum testosterone titres to normalcy. Total and free cholesterol concentrations remained unaltered in both MTX and MTX + LCN treated groups. On the other hand, a marked increase in esterified cholesterol concentration was evident only in weekly dose treatment groups. The specific activities of 3beta- and 17beta-hydroxy steroid dehydrogenase were markedly diminished in both MTX and MTX + LCN treated groups. The results suggest the inhibitory effect of MTX on steroidogenesis.
No takes yet. Share an insight, caveat, or question.
Badri et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: